Latest papers

Epidemiology and management of refractory lupus nephritis

Systemic inflammation in the elderly.

Allogeneic HLA-A*02-restricted WT1-specific T cells from mismatched donors are highly reactive but show off-target promiscuity.

Highlights of the second international conference on "Immunotherapy in Pediatric Oncology".

A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors.

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.

Complex interplays in immune T-cell differentiation and developmental fate determination.

New approaches to the treatment of pancreatic cancer: from tumor-directed therapy to immunotherapy.

Immunotherapeutic modulation of the suppressive liver and tumor microenvironments.

Meeting report: regulatory myeloid cells.

Endogenous lectins shape the function of dendritic cells and tailor adaptive immunity: mechanisms and biomedical applications.

Translating scientific advancement into clinical benefit for castration-resistant prostate cancer patients.

Novel targeted therapies and vaccination strategies for mesothelioma.

A new tumor vaccine: FAPτ-MT elicits effective antitumor response by targeting indolamine2,3-dioxygenase in antigen presenting cells.

Proceedings of the Second International Conference on Regulatory T Cells and Th17 Cells and Clinical Application in Human Diseases. July 17-20, 2010, Shanghai, China.

Case report of extensive metabolism by aldehyde oxidase in humans: Pharmacokinetics and metabolite profile of FK3453 in rats, dogs, and humans

Induction of immune tolerance in asthmatic mice by vaccination with DNA encoding an allergen-cytotoxic T lymphocyte-associated antigen 4 combination.

Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy.

CD40 pathway activation status predicts response to CD40 therapy in diffuse large B cell lymphoma.

Heterogeneity versus homogeneity of multiple sclerosis.